Cadrenal Therapeutics, Inc. Common Stock (CVKD) — Analyst estimates
Consensus analyst estimates for Cadrenal Therapeutics, Inc. Common Stock — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -1.35 | 1 |
| 2027 | 6.30M | -3.42 | 1 |
| 2028 | 16.80M | -2.61 | 2 |
| 2029 | 0 | 8.55 | 1 |
Consensus analyst estimates by fiscal year.